Cointime

U.S. Army Medical Research & Development Command

investment firm

About

USAMRMC is conducts research to deliver the medical solutions to enhance, protect and treat the warfighter.

  • Maryland,Louisiana,United States

Highlights

Investments
7
Lead Investments
6
Exits
3

Details

Founded date
Nov 3, 1994
Operating Status
Active
Legal Name
U.S. Army Medical Research & Development Command

Investments

Number of Investments
Number of Lead Investments
7
6
U.S. Army Medical Research & Development Command has made 7 investments. Their most recent investment was on May 26, 2021, when Inhalon Biopharma raised $7M.
Date Company Name
Round Money Raised Industry Lead Investor
May 26, 2021 Inhalon Biopharma
Grant $7M Biopharma Yes
May 18, 2021 Oculogica
Grant $2M Health Care Yes
Sep 24, 2020 Lumen Bioscience
Grant $4M Biopharma Yes
Feb 19, 2018 Medcura
Grant $1.40M Health Care Yes
Aug 14, 2017 Cytosorbents
Grant $719K Biotechnology Yes
Show More

Exits

U.S. Army Medical Research & Development Command has had 3 exits. U.S. Army Medical Research & Development Command most notable exits include SmartCells ,   Cytosorbents

Date Company Name Exit Type Industry
Dec 2, 2010 SmartCells M&A Biotechnology Detail
Aug 18, 2006 Cytosorbents IPO Biotechnology Detail
Feb 20, 1998 Lexicon Pharmaceuticals IPO Bioinformatics Detail
Cointime
Содержание
компания